BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 19251309)

  • 1. A phase I study of docetaxel as a radio-sensitizer for locally advanced squamous cell cervical cancer.
    Alvarez EA; Wolfson AH; Pearson JM; Crisp MP; Mendez LE; Lambrou NC; Lucci JA
    Gynecol Oncol; 2009 May; 113(2):195-9. PubMed ID: 19251309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer.
    Ryu SY; Lee WM; Kim K; Park SI; Kim BJ; Kim MH; Choi SC; Cho CK; Nam BH; Lee ED
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e577-81. PubMed ID: 21840137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I study of topotecan and radiation therapy in advanced cervical cancer.
    Dunton CJ; King SA; Neufeld J; Tolosa J; Perez G; Avila A; Underhill K
    Gynecol Oncol; 2002 Apr; 85(1):185-7. PubMed ID: 11925142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent weekly cisplatin and radiotherapy in routine management of cervical cancer: a report on patient compliance and acute toxicity.
    Serkies K; Jassem J
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):814-21. PubMed ID: 15465198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase one dose finding study of capecitabine (Xeloda), radiotherapy and cisplatin in the treatment of locally advanced squamous cervical cancer.
    Stokes Z; Symonds P; Habeshaw T; Reed N; Curto J; Joynson C; Chan S
    Gynecol Oncol; 2005 Jun; 97(3):790-5. PubMed ID: 15894361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weekly low-dose docetaxel-based chemoradiotherapy for locally advanced oropharyngeal or hypopharyngeal carcinoma: a retrospective, single-institution study.
    Fukada J; Shigematsu N; Takeda A; Ohashi T; Tomita T; Shiotani A; Kunieda E; Kawaguchi O; Fujii M; Kubo A
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):417-24. PubMed ID: 19409727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent chemoradiotherapy with paclitaxel and nedaplatin followed by consolidation chemotherapy in locally advanced squamous cell carcinoma of the uterine cervix: preliminary results of a phase II study.
    Zhang MQ; Liu SP; Wang XE
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):821-7. PubMed ID: 20207507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximum tolerated dose and early response - results of a phase I trial of paclitaxel and cisplatin with radiation therapy in carcinoma of the cervix.
    Prasad E; Viswanathan PN; Rangad VF; Pavamani S; Ram TS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):488-93. PubMed ID: 19386478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II study of weekly docetaxel for patients with advanced or recurrent cancer of the cervix.
    Pearl ML; Johnston CM; McMeekin DS
    Gynecol Obstet Invest; 2007; 64(4):193-8. PubMed ID: 17664880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients.
    Katanyoo K; Tangjitgamol S; Chongthanakorn M; Tantivatana T; Manusirivithaya S; Rongsriyam K; Cholpaisal A
    Gynecol Oncol; 2011 Dec; 123(3):571-6. PubMed ID: 21955483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of locally advanced cervical cancer with concurrent radiation and intra-arterial chemotherapy.
    Morris M; Eifel PJ; Burke TW; McNamara MM; Levenback C; Kavanagh JJ; Gershenson DM
    Gynecol Oncol; 1995 Apr; 57(1):72-8. PubMed ID: 7705704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase I/II trial of weekly docetaxel and concomitant radiotherapy for squamous cell carcinoma of the head and neck.
    Fujii M; Tsukuda M; Satake B; Kubota A; Kida A; Kohno N; Okami K; Inuyama Y;
    Int J Clin Oncol; 2004 Apr; 9(2):107-12. PubMed ID: 15108042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and initial phase II results from a trial investigating weekly docetaxel and carboplatin given neoadjuvantly and then concurrently with concomitant boost radiotherapy for locally advanced squamous cell carcinoma of the head and neck.
    Schwartz DL; Montgomery RB; Yueh B; Donahue M; Anzai Y; Canby R; Buelna R; Anderson L; Boyd C; Hutson J; Keegan K
    Cancer; 2005 Jun; 103(12):2534-43. PubMed ID: 15856475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase I trial of concurrent chemoradiation with weekly nedaplatin in patients with squamous cell carcinoma of the uterine cervix.
    Yoshinaga K; Niikura H; Ogawa Y; Nemoto K; Nagase S; Takano T; Ito K; Yaegashi N
    Gynecol Oncol; 2007 Jan; 104(1):36-40. PubMed ID: 16889822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature results of a phase II trial of concomitant cisplatin/pelvic radiotherapy for locally advanced squamous cell carcinoma of the cervix.
    Fields AL; Anderson PS; Goldberg GL; Wadler S; Beitler J; Sood B; Runowicz CD
    Gynecol Oncol; 1996 Jun; 61(3):416-22. PubMed ID: 8641625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.